| Literature DB >> 29204247 |
María José Vallejo1, Lizeth Salazar2, Marcelo Grijalva1,2.
Abstract
Medicinal and aromatic plants (MAPs) are known and have been long in use for a variety of health and cosmetics applications. Potential pharmacological usages that take advantage of bioactive plant-derived compounds' antimicrobial, antifungal, anti-inflammatory, and antioxidant properties are being developed and many new ones explored. Some phytochemicals could trigger ROS-mediated cytotoxicity and apoptosis in cancer cells. A lot of effort has been put into investigating novel active constituents for cancer therapeutics. While other plant-derived compounds might enhance antioxidant defenses by either radical scavenging or stimulation of intracellular antioxidant enzymes, the generation of reactive oxygen species (ROS) leading to oxidative stress is one of the strategies that may show effective in damaging cancer cells. The biochemical pathways involved in plant-derived bioactive compounds' properties are complex, and in vitro platforms have been useful for a comprehensive understanding of the mechanism of action of these potential anticancer drugs. The present review aims at compiling the findings of particularly interesting studies that use cancer cell line models for assessment of antioxidant and oxidative stress modulation properties of plant-derived bioactive compounds.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29204247 PMCID: PMC5674509 DOI: 10.1155/2017/4586068
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Plant-derived natural products approved for cancer treatment.
| Class | Isolated from | Mechanism of action | References |
|---|---|---|---|
|
|
| Disruption of formation of the mitotic spindle; tubulin inhibitors; deregulation of actin cytoskeletons; microtubule destabilization and depolymerization; cell death via apoptosis. | [ |
|
|
| Cell cycle arrest; DNA strand damage; cell death via apoptosis. | [ |
| Taxanes (paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, docetaxel, cabizitaxel) |
| Mitotic inhibitors; microtubule disruptors; apoptosis is induced through stabilization of microtubules. | [ |
| Camptothecins (irinotecan and topotecan) |
| Inhibition of the nuclear protein topoisomerase I. | [ |
Figure 1Classification of reactive species produced by cells [30, 31].
Figure 2Number of publications related with plant extracts, cancer, and in vitro.
Figure 3Most commonly used methods for MAP evaluation on in vitro cancer cell line models.